Some patients with asthma may fail to respond to what appears to be an adequate dose of corticosteroids. The underlying reason for this failure can usually be found by a careful assessment of the patient.
Underlying Cause |
Features |
poor adherence to therapy |
The patient admits to poor compliance. The patient responds to observed therapy. |
deteriorated drug |
The drug shows signs of deterioration or is outdated. The patient responds to a new drug supply. |
failure in drug delivery or absorption |
The patient responds to steroids given by a different route or a different delivery system. |
pseudo-asthma |
The patient responds to treatment of the condition mimicking asthma. |
drug interaction increasing steroid metabolism |
Discontinuation of the interfering drug corrects problem. |
panic attack |
Treatment of anxiety corrects the problem. |
continued exposure to triggering agent, including an unrecognized triggering agent |
The history may indicate the source. The patient responds to steroids once the exposure stops. |
excessive exposure to beta-agonists |
The patient responds once beta-agonist therapy is reduced. |
cytokine-induced steroid resistance (Type I Steroid Resistance) |
The patient responds to steroids once the cause of cytokine release is corrected. |
hereditary resistance (Type II Steroid Resistance) |
No response to steroids at any time. Family members may also be affected. Demonstration of genetic defect. |
Cytokine-induced steroid resistance occurs because of increased expression of glucocorticoid receptor beta. This is a less active isoform of the receptor.
Hereditary resistance is due to decreased numbers of functional glucocorticoid receptors.
Specialty: Pulmonology